X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20210415005547/en/AFYX-Therapeutics-Presents-Phase-2-Data-of-Rivelin-CLO-at-2021-AAOM-Virtual-Conference
https://eyewire.news/articles/qlaris-bio-enrolls-first-patient-in-phase-1-2-studies-of-investigational-glaucoma-drug-qls-101/